American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2014, 2(1), 30-31
DOI: 10.12691/ajmcr-2-1-10
Open AccessCase Report

Aggressive Progression of Mantle Cell Lymphoma: A Case Report

Ilknur Nizam1, , Mehmet Ali Erkurt1, Ilhami Berber1, Emin Kaya1, Irfan Kuku1 and Mustafa Koroglu1

1Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey

Pub. Date: February 11, 2014

Cite this paper:
Ilknur Nizam, Mehmet Ali Erkurt, Ilhami Berber, Emin Kaya, Irfan Kuku and Mustafa Koroglu. Aggressive Progression of Mantle Cell Lymphoma: A Case Report. American Journal of Medical Case Reports. 2014; 2(1):30-31. doi: 10.12691/ajmcr-2-1-10

Abstract

Mantle cell lymphoma is a relatively rare disease, mostly affecting the elderly. It behaves aggressively although it has features of an indolent lymphoma. Here, we presented a case of an 85-year old female patient applying to emergency service with difficulty in breathing due to huge lumps around her neck. She had mantle cell lymphoma which has aggressively progressed despite chemotherapy. She was at an advanced stage of the disease and taken to the intensive care unit. Despite best supportive care, steroid therapy and respiratory support, she passed away within 24 hours.

Keywords:
mantle cell lymphoma stem cell transplantation MIPI

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood 1997; 89: 3909-3918.
 
[2]  Andersen NS, Jensen MK, de Nully Brown P, Geisler CH. A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors. Eur J Cancer 2002; 38: 401-408.
 
[3]  Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008 Jan 15; 111 (2): 558-65.
 
[4]  Caballero D, Campo E, López-Guillermo A, Martín A, Arranz-Sáez R et al. Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group. Ann Hematol. 2013 Sep; 92 (9): 1151-79.
 
[5]  Perez-Galan P, Dreyling M, Wiestner A.Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood. 2011; 117 (1): 26-38.
 
[6]  Williams ME. Transplantation for mantle cell lymphoma: is it the right thing to do? Hematology Am Soc Hematol Educ Program. 2013; 2013: 568-74.